Back to Search
LISA REEVES, MD
MD
Specialist
NPI: 1568494185IndividualAccepts Medicare
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
LR058110(MI)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
UNIVERSITY OF MICHIGAN MEDICAL SCHOOL
Class of 1991
Research & Publications (20)
Copy number determination of genetically-modified hematopoietic stem cells.
PMID 19110633·Methods Mol Biol·2009
8-other
Release testing of retroviral vectors and gene-modified cells.
PMID 19110632·Methods Mol Biol·2009
6-review
Database setup for preclinical studies of gene-modified hematopoiesis.
PMID 19110645·Methods Mol Biol·2009
7-preclinical
Defective homing is associated with altered Cdc42 activity in cells from patients with Fanconi anemia group A.
PMID 18565850·Blood·2008
7-preclinical
Immediate and short-term effects of the 5th grade version of the keepin' it REAL substance use prevention intervention.
PMID 19157042·J Drug Educ·2008
2-rct
Culture in the classroom: developing teacher proficiency in delivering a culturally-grounded prevention curriculum.
PMID 18807191·J Prim Prev·2008
8-other
21st century human-system computing: augmented cognition for improved human performance.
PMID 17547299·Aviat Space Environ Med·2007
8-other
Importance of murine study design for testing toxicity of retroviral vectors in support of phase I trials.
PMID 17299409·Mol Ther·2007
7-preclinical
Lentiviral vectors pseudotyped with murine ecotropic envelope: increased biosafety and convenience in preclinical research.
PMID 16647564·Exp Hematol·2006
7-preclinical
A pilot study of dose-intensified procarbazine, CCNU, vincristine for poor prognosis brain tumors utilizing fibronectin-assisted, retroviral-mediated modification of CD34+ peripheral blood cells with O6-methylguanine DNA methyltransferase.
PMID 16645619·Cancer Gene Ther·2006
3-trial
Evaluation of nonpharmacologic methods of pain and anxiety management for laceration repair in the pediatric emergency department.
PMID 16585311·Pediatrics·2006
2-rct
Discovery of 3-OH-3-methylpipecolic hydroxamates: potent orally active inhibitors of aggrecanase and MMP-13.
PMID 15953722·Bioorg Med Chem Lett·2005
7-preclinical
Cardiovascular disease event classification in the Jackson Heart Study: methods and procedures.
PMID 16317987·Ethn Dis·2005
8-other
Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanase and MMP-13.
PMID 15911259·Bioorg Med Chem Lett·2005
8-other
3-Hydroxy-4-arylsulfonyltetrahydropyranyl-3-hydroxamic acids are novel inhibitors of MMP-13 and aggrecanase.
PMID 15324896·Bioorg Med Chem Lett·2004
4-observational
Synthesis and biological activity of piperazine-based dual MMP-13 and TNF-alpha converting enzyme inhibitors.
PMID 12951101·Bioorg Med Chem Lett·2003
7-preclinical
Detection of ecotropic replication-competent retroviruses: comparison of s(+)/l(-) and marker rescue assays.
PMID 12396630·Hum Gene Ther·2002
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 20176 LIVERNOIS AVE
DETROIT, MI 48221 - Phone
- (313) 864-3000
Quick Facts
- NPI
- 1568494185
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 35
- Publications
- 20
Are you this provider?
Claim Your Profile